- Email: [email protected]
The Top Ten
european urology 50 (2006) 388
available at www.sciencedirect.com journal homepage: www.europeanurology.com
The Top Ten Readers’ most popular articles in: APRIL 2006 This is a list of the top ten most downloaded articles from ScienceDirect during the calendar month of April 2006, highlighting the articles which you, the readers, have been downloading and reading the most. We count downloads as the number of articles downloaded as full text or PDF during this month. Please note, this list is compiled with a four month delay in order to properly calculate reader downloads. 1. EAU Guidelines on Erectile Dysfunction: An Update Wespes, E.; Amar, E.; Hatzichristou, D.; Hatzimouratidis, K.; Montorsi, F.; Pryor, J.; Vardi, Y. European Urology 2006;49:806–815. 2. 2004 WHO Classification of the Renal Tumors of the Adults Lopez-Beltran, A.; Scarpelli, M.; Montironi, R.; Kirkali, Z. European Urology 2006;49:798–805. 3. A Comparison of the Efficacy and Tolerability of Solifenacin Succinate and Extended Release Tolterodine at Treating Overactive Bladder Syndrome: Results of the STAR Trial Chapple, C.R.; Martinez-Garcia, R.; Selvaggi, L.; Toozs-Hobson, P.; Warnack, W.; Drogendijk, T.; Wright, D.M.; Bolodeoku, J. for the STAR study group European Urology 2005;48:465–470. 4. A Shifted Paradigm for the Further Understanding, Evaluation, and Treatment of Lower Urinary Tract Symptoms in Men: Focus on the Bladder Chapple, C.R.; Roehrborn, C.G. European Urology 2006;49:651–659. 5. Prescribing All Phosphodiesterase 5 Inhibitors to a Patient with Erectile Dysfunction—A Realistic and Feasible Option in Everyday Clinical Practice—Outcomes of a Simple Treatment Regime Stroberg, P.; Hedelin, H.; Ljunggren, C. European Urology 2006;49:900–907.
0302-2838/$ – see back matter
doi:10.1016/S0302-2838(06)00691-9
6. Understanding the Importance of Smart Drugs in Renal Cell Carcinoma Patard, J.J.; Rioux-Leclercq, N.; Fergelot, P. European Urology 2006;49:633–643. 7. EAU Guidelines on Prostate Cancer Aus, G.; Abbou, C.C.; Bolla, M.; Heidenreich, A.; Schmid, H.P.; van Poppel, H.; Wolff, J.; Zattoni, F. European Urology 2005;48:546–551. 8. Management of BCG Failures in Superficial Bladder Cancer: A Review Witjes, J.A. European Urology 2006;49:790–797. 9. The Effects of Antimuscarinic Treatments in Overactive Bladder: A Systematic Review and Meta-Analysis Chapple, C.; Khullar, V.; Gabriel, Z.; Dooley, J.A. European Urology 2005;48:5–26. 10. Evaluation of Male Sexual Function in Patients with Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH) Treated with a Phytotherapeutic Agent (Permixon1), Tamsulo Zlotta, A.R.; Teillac, P.; Raynaud, J.P.; Schulman, C.C. European Urology 2005;48:269–276.
available at www.sciencedirect.com journal homepage: www.europeanurology.com
The Top Ten Readers’ most popular articles in: APRIL 2006 This is a list of the top ten most downloaded articles from ScienceDirect during the calendar month of April 2006, highlighting the articles which you, the readers, have been downloading and reading the most. We count downloads as the number of articles downloaded as full text or PDF during this month. Please note, this list is compiled with a four month delay in order to properly calculate reader downloads. 1. EAU Guidelines on Erectile Dysfunction: An Update Wespes, E.; Amar, E.; Hatzichristou, D.; Hatzimouratidis, K.; Montorsi, F.; Pryor, J.; Vardi, Y. European Urology 2006;49:806–815. 2. 2004 WHO Classification of the Renal Tumors of the Adults Lopez-Beltran, A.; Scarpelli, M.; Montironi, R.; Kirkali, Z. European Urology 2006;49:798–805. 3. A Comparison of the Efficacy and Tolerability of Solifenacin Succinate and Extended Release Tolterodine at Treating Overactive Bladder Syndrome: Results of the STAR Trial Chapple, C.R.; Martinez-Garcia, R.; Selvaggi, L.; Toozs-Hobson, P.; Warnack, W.; Drogendijk, T.; Wright, D.M.; Bolodeoku, J. for the STAR study group European Urology 2005;48:465–470. 4. A Shifted Paradigm for the Further Understanding, Evaluation, and Treatment of Lower Urinary Tract Symptoms in Men: Focus on the Bladder Chapple, C.R.; Roehrborn, C.G. European Urology 2006;49:651–659. 5. Prescribing All Phosphodiesterase 5 Inhibitors to a Patient with Erectile Dysfunction—A Realistic and Feasible Option in Everyday Clinical Practice—Outcomes of a Simple Treatment Regime Stroberg, P.; Hedelin, H.; Ljunggren, C. European Urology 2006;49:900–907.
0302-2838/$ – see back matter
doi:10.1016/S0302-2838(06)00691-9
6. Understanding the Importance of Smart Drugs in Renal Cell Carcinoma Patard, J.J.; Rioux-Leclercq, N.; Fergelot, P. European Urology 2006;49:633–643. 7. EAU Guidelines on Prostate Cancer Aus, G.; Abbou, C.C.; Bolla, M.; Heidenreich, A.; Schmid, H.P.; van Poppel, H.; Wolff, J.; Zattoni, F. European Urology 2005;48:546–551. 8. Management of BCG Failures in Superficial Bladder Cancer: A Review Witjes, J.A. European Urology 2006;49:790–797. 9. The Effects of Antimuscarinic Treatments in Overactive Bladder: A Systematic Review and Meta-Analysis Chapple, C.; Khullar, V.; Gabriel, Z.; Dooley, J.A. European Urology 2005;48:5–26. 10. Evaluation of Male Sexual Function in Patients with Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH) Treated with a Phytotherapeutic Agent (Permixon1), Tamsulo Zlotta, A.R.; Teillac, P.; Raynaud, J.P.; Schulman, C.C. European Urology 2005;48:269–276.